Binding Optimization through Coordination Chemistry: CXCR4 Chemokine Receptor Antagonists from Ultrarigid Metal Complexes
- 20 February 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 131 (10), 3416-3417
- https://doi.org/10.1021/ja807921k
Abstract
A new copper(II) containing bis-macrocyclic CXCR4 chemokine receptor antagonist is shown to have improved binding properties to the receptor protein in comparison to the drug AMD3100 (Plerixafor, Mozobil). The interaction of the metallodrug has been optimized by using ultrarigid chelator units that offer an equatorial site for coordination to the amino acid side chains of the protein. Binding competition assays with anti-CXCR4 antibodies show that the new compound stays bound longer and it has improved anti-HIV potency in vitro (EC50 = 4.3 nM). X-ray structural studies using acetate as a model for carboxylate amino acid side chains indicate the nature of the coordination interaction.This publication has 16 references indexed in Scilit:
- Residence Time of Receptor−Ligand Complexes and Its Effect on Biological FunctionBiochemistry, 2008
- Probing key coordination interactions: configurationally restricted metal activated CXCR4 antagonistsDalton Transactions, 2007
- Fluorescent CXCR4 chemokine receptor antagonists: metal activated bindingChemical Communications, 2006
- Configurationally Restricted Bismacrocyclic CXCR4 Receptor AntagonistsJournal of Medicinal Chemistry, 2006
- Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonistThe Journal of Experimental Medicine, 2005
- The bicyclam AMD3100 storyNature Reviews Drug Discovery, 2003
- Metal Ion Enhanced Binding of AMD3100 to Asp262 in the CXCR4 ReceptorBiochemistry, 2002
- Structure and Dynamics of Metallomacrocycles: Recognition of Zinc Xylyl-Bicyclam by an HIV CoreceptorJournal of the American Chemical Society, 2002
- Mutation of Asp171and Asp262of the Chemokine Receptor CXCR4 Impairs Its Coreceptor Function for Human Immunodeficiency Virus-1 Entry and Abrogates the Antagonistic Activity of AMD3100Molecular Pharmacology, 2001
- Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.Proceedings of the National Academy of Sciences of the United States of America, 1992